Cargando…
Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
Fructose is one of the key dietary catalysts in the development of non-alcoholic fatty liver disease (NAFLD). NAFLD comprises a complex disease spectrum, including steatosis (fatty liver), non-alcoholic steatohepatitis, hepatocyte injury, inflammation, and fibrosis. It is also the hepatic manifestat...
Autores principales: | Lambertz, Jessica, Weiskirchen, Sabine, Landert, Silvano, Weiskirchen, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609573/ https://www.ncbi.nlm.nih.gov/pubmed/28970836 http://dx.doi.org/10.3389/fimmu.2017.01159 |
Ejemplares similares
-
Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021) -
Lipocalin-2 in Fructose-Induced Fatty Liver Disease
por: Lambertz, Jessica, et al.
Publicado: (2017) -
Lipocalin 2 receptors: facts, fictions, and myths
por: Schröder, Sarah K., et al.
Publicado: (2023) -
All You Can Feed: Some Comments on Production of Mouse Diets Used in Biomedical Research with Special Emphasis on Non-Alcoholic Fatty Liver Disease Research
por: Weiskirchen, Sabine, et al.
Publicado: (2020) -
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
por: Tacke, Frank, et al.
Publicado: (2021)